Apotea up 73% since insider buying in February
- Insider
- Laulima
- Role
- Closely associated: Chief Executive Officer (VD)
- Company
- Apotea (APOTEA)
- Transaction
- Buy
- Shares
- 475,000
- Amount
- SEK 29.7M
- Price per share
- SEK 62.55
- Trade date
- Feb 4, 2026
- Filed
- Feb 4, 2026, 0 days after the trade
- Source
- Finansinspektionen ↗
Laulima, closely associated with the CEO of Apotea, bought 475,000 shares at SEK 62.55 on Feb 4, 2026, for SEK 29.7M. One other Apotea insider, Tromelin, also disclosed a purchase that day.
Apotea traded at SEK 104.40 at 09:24 CET on November 6, 2026, 72.9% above the first close after the purchase, SEK 60.39 on Feb 5, 2026. The price is delayed by 15 to 20 minutes.
No sales by Laulima in Apotea have been reported since.
APOTEA +0.1% on the day, delayed quote Nov 6
Since purchase+72.9%SEK 60.39 → SEK 104.40 at 09:24 CET
Since filing+72.9%SEK 60.39 on Feb 5 → SEK 104.40
PurchaseSEK 29.7M475,000 shares on Feb 4, 2026
Days since purchase275No sales by this filer since
Price since the purchase
Daily close · SEK+70%
0%
Feb 5 · first close 60.39 SEKNov 6 · 104.40 SEK
PurchaseFirst close above +70%